Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $24.43 million. The enterprise value is $52.18 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 30.35 million shares outstanding. The number of shares has increased by 5.49% in one year.
| Current Share Class | 30.35M |
| Shares Outstanding | 30.35M |
| Shares Change (YoY) | +5.49% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 6.77% |
| Owned by Institutions (%) | 28.73% |
| Float | 26.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 0.28 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 5.19.
| Current Ratio | 3.16 |
| Quick Ratio | 2.44 |
| Debt / Equity | 5.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.46 |
Financial Efficiency
Return on equity (ROE) is -153.94% and return on invested capital (ROIC) is -23.42%.
| Return on Equity (ROE) | -153.94% |
| Return on Assets (ROA) | -19.09% |
| Return on Capital (ROIC) | -23.42% |
| Revenue Per Employee | $358,182 |
| Profits Per Employee | -$179,424 |
| Employee Count | 203 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.56% in the last 52 weeks. The beta is 2.22, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | -40.56% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 44.62 |
| Average Volume (20 Days) | 801,010 |
Short Selling Information
The latest short interest is 735,036, so 2.42% of the outstanding shares have been sold short.
| Short Interest | 735,036 |
| Short Previous Month | 711,076 |
| Short % of Shares Out | 2.42% |
| Short % of Float | 2.80% |
| Short Ratio (days to cover) | 4.05 |
Income Statement
In the last 12 months, Neuronetics had revenue of $72.71 million and -$36.42 million in losses. Loss per share was -$1.23.
| Revenue | 72.71M |
| Gross Profit | 56.94M |
| Operating Income | -25.52M |
| Pretax Income | -27.54M |
| Net Income | -36.42M |
| EBITDA | -23.48M |
| EBIT | -25.52M |
| Loss Per Share | -$1.23 |
Full Income StatementBalance Sheet
The company has $20.87 million in cash and $48.70 million in debt, giving a net cash position of -$27.83 million or -$0.92 per share.
| Cash & Cash Equivalents | 20.87M |
| Total Debt | 48.70M |
| Net Cash | -27.83M |
| Net Cash Per Share | -$0.92 |
| Equity (Book Value) | 9.38M |
| Book Value Per Share | 0.31 |
| Working Capital | 36.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.27 million and capital expenditures -$2.26 million, giving a free cash flow of -$22.52 million.
| Operating Cash Flow | -20.27M |
| Capital Expenditures | -2.26M |
| Free Cash Flow | -22.52M |
| FCF Per Share | -$0.74 |
Full Cash Flow StatementMargins
Gross margin is 78.31%, with operating and profit margins of -35.10% and -50.09%.
| Gross Margin | 78.31% |
| Operating Margin | -35.10% |
| Pretax Margin | -50.09% |
| Profit Margin | -50.09% |
| EBITDA Margin | -32.29% |
| EBIT Margin | -35.10% |
| FCF Margin | -42.81% |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.49% |
| Shareholder Yield | -5.49% |
| Earnings Yield | -148.17% |
| FCF Yield | -91.63% |
Analyst Forecast
The average price target for Neuronetics is $4.67, which is 480.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.67 |
| Price Target Difference | 480.12% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 16.58% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -6.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.62 |
| Piotroski F-Score | 3 |